Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - OTHER LONG-TERM ASSETS
Other Long-term Assets KALV - KalVista Pharmaceuticals, Inc.
567 K
LAST VALUE
71.40%
2 YEAR CAGR
26.80%
5 YEAR CAGR
16.80%
10 YEAR CAGR